首页> 外文会议>PUMC-CCF International Anesthesia Symposium >Perioperative Anesthetic Management for the Excision of Pheochromocytoma
【24h】

Perioperative Anesthetic Management for the Excision of Pheochromocytoma

机译:围手术期麻醉治疗,用于切除嗜铬细胞瘤

获取原文

摘要

Although surgical treatment for patients with pheochromocytoma and its perioperative management has been well developed in recent years, anesthetic management is still highly stressful during the resection of "complicated" pheochromocytoma, such as catechlamine cardiomyopathy, pheochromocytoma crisis, multiple endocrine neoplasia (MEN), and severe surgical difficulties(e.g. location in the heart, liver, or a giant pheochromocytoma surrounding large vessels), etc. The anesthetic management for the excision of pheochromocytoma not only includes selects appropriate anesthetics for the surgical procedures, but also extends to the preoperative preparation and circulatory support postoperatively. It is essential for anesthesiologist to make individualized protocols for these high-risk surgical procedures, based on a thorough understanding of the pathophysiological characteristics of pheochromocytomas and related surgical procedures, as well as good communication among the specialists involved in the treatment.
机译:虽然近年来对嗜铬细胞瘤的患者及其围手术期管理的外科治疗,但在切除“复杂”嗜铬细胞瘤,如Catechamine心肌病,嗜铬细胞瘤危机,多个内分泌瘤(男子),并且严重的手术困难(例如,心脏,肝脏或围绕大血管的巨型嗜铬细胞瘤的位置)等。用于切除伯粒细胞瘤的麻醉管理不仅包括用于外科手术的适当麻醉剂,而且还延伸到术前制剂和术前制剂术后循环支持。基于对嗜铬细胞瘤和相关手术程序的病理生理学特征的彻底了解,对这些高风险外科手术进行个性化方案,对这些高风险的手术进行个性化方案,以及参与治疗的专家之间的良好沟通。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号